Intermolecular Downgraded to “Hold” at Needham & Company (IMI)
Intermolecular (NASDAQ:IMI) was downgraded by research analysts at Needham & Company from a “buy” rating to a “hold” rating in a report released on Monday, TheFlyOnTheWall.com reports.
Shares of Intermolecular (NASDAQ:IMI) traded down 9.84% on Monday, hitting $4.40. The stock had a trading volume of 546,912 shares. Intermolecular has a 52-week low of $4.81 and a 52-week high of $10.69. The stock’s 50-day moving average is $5.42 and its 200-day moving average is $6.04. The company’s market cap is $202.9 million.
Intermolecular (NASDAQ:IMI) last posted its quarterly earnings results on Thursday, October 24th. The company reported ($0.05) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.03) by $0.02. The company had revenue of $17.70 million for the quarter, compared to the consensus estimate of $15.50 million. During the same quarter last year, the company posted $0.02 earnings per share. Intermolecular’s revenue was up 7.3% compared to the same quarter last year. Analysts expect that Intermolecular will post $-0.07 EPS for the current fiscal year.
Intermolecular, Inc (NASDAQ:IMI) is engaged in research and development and time-to-market for the semiconductor and clean-energy industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.